The hepatitis C virus (HCV) induces alterations of host cells to facilitate its life cycle. Fatty acid synthase (FASN) is a multidomain enzyme that plays a key role in the biosynthesis of fatty acids and is upregulated during HCV infection. Herein, we applied activity-based protein profiling (ABPP) that allows for the identification of differentially active enzymes in complex proteomic samples, to study the changes in activity of FASN during HCV replication. For this purpose, we used an activity-based probe based on the FASN inhibitor Orlistat, and observed an increase in the activity of FASN in the presence of a subgenomic and a genomic HCV replicon as well as in chimeric SCID/Alb-uPA mice infected with HCV genotype 1a. To study the molecular basis for this increase in FASN activity, we overexpressed individual HCV proteins in Huh7 cells and observed increased expression and activity of FASN in the presence of core and NS4B, as measured by western blots and ABPP, respectively. Triglyceride levels were also elevated in accordance with FASN expression and activity. Lastly, immunofluorescence and ABPP imaging analyses demonstrated that while the abundance and activity of FASN increases significantly in the presence of HCV, its localization does not change. Together these data suggest that the HCV-induced production of fatty acids and neutral lipids is provided by an increase in FASN abundance and activity that is sufficient to allow HCV propagation without transporting FASN to the replication complexes.
INTRODUCTION
Hepatitis C virus (HCV) is a growing health problem and currently infects about 3% of the global population (Shepard et al., 2005) . HCV infection causes chronic liver disease, which leads to steatosis, cirrhosis, and hepatocellular carcinoma (Ghany, 2009) . This virus belongs to the Flaviviridae family and its genome consists of a positive sense RNA that is approximately 9.6 kb long, and encodes an $3,000 amino acid polyprotein, which is processed into three structural proteins (core, E1, and E2) that form the mature virion, as well as seven nonstructural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B), which are involved in viral replication (Grakoui et al., 1993) . Similar to other viruses, HCV depends on the host machinery to complete its life cycle. New methods to identify and study these complex interactions are needed to uncover the mechanisms by which HCV propagates and, ultimately, to develop novel strategies to combat the infection.
HCV depends on host cell lipid biosynthesis and altered membrane structures to efficiently replicate (Kapadia and Chisari, 2005; Miyanari et al., 2007; Pezacki et al., 2010; Sagan et al., 2006; Bassendine et al., 2011; Herker and Ott, 2011; Bugianesi et al., 2012) . Numerous genome-wide RNAi screens have revealed that the host genes involved in lipid metabolism, membrane biogenesis, and trafficking are crucial for HCV replication (Li et al., 2009; Tai et al., 2009) . HCV components, including those responsible for viral particle assembly, closely associate with lipid droplets (LD) (Boulant et al., 2007; Lyn et al., 2010) . Also, HCV has been shown to use various mechanisms to increase the cellular lipid content, including inducing lipid biosynthesis, impeding b-oxidation of fatty acids, and hindering secretion of very low-density lipoproteins (VLDL) (Bassendine et al., 2011; Mirandola et al., 2006; Perlemuter et al., 2002; Sheikh et al., 2008; Syed et al., 2010) . One of the key lipogenic enzymes whose expression is upregulated by HCV is fatty acid synthase (FASN; EC 2.3.1.85) (Fujino et al., 2010; Su et al., 2002; Yang et al., 2008) . Additionally, HCV infection has been correlated with increased FASN levels in the serum of infected patients (Aragonè s et al., 2010; Joven et al., 2011) . FASN is a 270 kDa multifunctional enzyme that contains seven enzymatic domains and harbors the complete pathway required to synthesize palmitic acid de novo from acetyl and malonyl esters of coenzyme A (CoA) (Wakil, 1989) . Importantly, while FASN activity appears to be essential for HCV replication, it does not seem to be required for adult tissue maintenance, as long as a normal diet is maintained (Chakravarthy et al., 2005; Lerat et al., 2009; Semenkovich, 1997) . Thus, FASN is an important host enzyme whose expression is altered by HCV, but HCV's influence on FASN enzyme activity and localization is not well established.
FASN enzyme activity is important in establishing infection of other RNA viruses through the creation of altered membrane structures. De novo lipid biosynthesis and incorporation of newly synthesized lipids at sites of viral replication are necessary for the replication of other members of the Flaviviridae family including Dengue virus (DENV), yellow fever virus (YFV), Usutu virus (USUV), and West Nile virus (WNV). Inhibition of FASN by small molecule inhibitors such as Cerulenin, Orlistat, and C75 leads to a drastic inhibition of viral replication (Heaton et al., 2010; Kapadia and Chisari, 2005; Martín-Acebes et al., 2011; Miyanari et al., 2007; Perera et al., 2012; Sagan et al., 2006; Su et al., 2002) . Interestingly, while the levels of FASN expression do not change significantly during DENV and WNV infection, its subcellular localization changes from the cytosol to being proximal to the sites of viral replication, so that nascent fatty acids can be utilized to establish or expand replication complexes (Heaton et al., 2010; Martín-Acebes et al., 2011; Perera et al., 2012) . However, it is not known whether HCV modifies FASN localization and activity in a similar fashion. Transcriptional activation of lipogenic enzymes, such as FASN and acetyl-CoA carboxylase (ACC), have been demonstrated during the HCV replication (Waris et al., 2007) . To date, however, it is not known whether these enzymes are catalytically active or if HCV recruits these enzymes to the vicinity of the HCV replication complexes.
FASN enzyme activity requires posttranslational activation. To be catalytically competent, the central acyl carrier domain (ACP) of FASN must be posttranslationally modified by an intrinsic phosphopantetheine transferase (PPT) that covalently attaches the phosphopantetheine moiety of coenzyme A (CoA) onto a conserved serine residue of the ACP (Johansson et al., 2009; Pemble et al., 2007; Schweizer and Hofmann, 2004) . Also, biotinylation is indispensable for the activity of ACC (PachecoAlvarez et al., 2004) . Traditional abundance-based approaches fail to report on the functional state of FASN and other enzymes. Therefore, novel experimental approaches are required to interrogate the catalytic state of lipogenic enzymes involved in HCV infection, and provide an in-depth analysis of the dynamic and transient interactions that affect the enzymatic function of host factors during viral replication.
Activity-based protein profiling (ABPP) was developed as a functional proteomics tool to report on the catalytic states of enzyme classes in native biological systems, assign function to proteins with unknown function, and provide insight into enzymes mechanisms (Barglow and Cravatt, 2007; Cravatt et al., 2008) . In this strategy, small molecule inhibitors, which are conjugated to reporter or affinity tags, are exploited to target the catalytic active sites of different enzyme classes (Barglow and Cravatt, 2007; Cravatt et al., 2008; Martin et al., 2011) . Labeled proteins are then purified and subsequently identified by mass spectrometry. ABPP has been successfully used to interrogate host-pathogen interactions and led to the discovery of novel host factors involved in viral pathogenesis (Blais et al., 2012; Marnett et al., 2004; Ovaa et al., 2004; Rolé n et al., 2006) . Furthermore, by applying several mechanisticallydifferent ABPs, our group has identified numerous enzymes encompassing many enzyme families that are differentially active during HCV replication (Blais et al., 2010a (Blais et al., , 2010b Singaravelu et al., 2010) . Given the significance of the lipogenic enzymes in the replication cycle of HCV, we were interested in examining the possible modulation of the activity of FASN by this virus. In this study, we used an ABP based on Orlistat, a US Food and Drug Administration (FDA)-approved drug (Padwal and Majumdar, 2007) and known inhibitor of FASN to investigate the HCV-induced alterations in the activity of FASN (Yang et al., 2010 (Yang et al., , 2011 (Yang et al., , 2012 . Herein, we find an increase in the expression and activity of FASN in the presence of HCV. We also observed that FASN activity is increased during overexpression of individual HCV proteins, such as core and NS4B, which leads to accumulation of triglyceride in the hepatic cells. Furthermore, we investigated the possible change in the localization of both total FASN and active FASN in the presence of HCV replicon and observed that while the abundance of both total and active FASN markedly increases during HCV replication, its localization does not change in contrast to what has been reported in DENV and WNV.
RESULTS

Protein Profiling Using Orlistat-Based Probes
Orlistat, or tetrahydrolipstatin (THL), is an FDA-approved drug against obesity (Ballinger and Peikin, 2002; Henness and Perry, 2006) that makes a covalent bond, through its b-lactone moiety, to the nucleophilic serine (Ser 2308 ) in the active site of the thioesterase (TE) domain of FASN (Figure S1A available online) (Pemble et al., 2007) . Orlistat is cell permeable (Knowles et al., 2004) and therefore makes a promising activity-based probe that can be applied both in situ and in vitro to report on the activity of its targets in the subcellular environment and homogenized cells or tissues, respectively. Moreover, minor structural modifications of Orlistat, such as introducing an alkyne handle, can be performed without having a drastic effect on its biological activity (Richardson et al., 2008; Yang et al., 2010) . As a result, conservative structural changes have been performed to the parental THL structure to convert Orlistat into a competent activity-based probe (Richardson et al., 2008; Yang et al., 2011) . In addition, an alkyne handle has been introduced to the THL structure, which allows for conjugation of the protein/probe complex to reporter and affinity tags via bio-orthogonal click chemistry (Evans and Cravatt, 2006; Yang et al., 2010) .
First, a library of seven Orlistat-based probes ( Figure S1B ), which has already been applied to target FASN in HepG2 cells (Yang et al., 2011) , was screened for its specificity against FASN in Huh7 cells. For this purpose, in situ (data not shown) and in vitro ( Figure S1C ) labeling was carried out and the reaction products were separated by SDS-PAGE and visualized in-gel using a flatbed fluorescence scanner. As demonstrated, the Orlistat analog probes 1 to 5 all labeled FASN whereas analogs 6 and 7 did not label FASN appreciably. We chose probe 2 (Figure 1A) for further experiments because it shows a strong specific activity-based labeling toward its FASN target. Overall, these results demonstrate that the Orlistat-based probe can function as an activity-based probe in Huh7 human hepatoma cells to report on the activity of FASN.
Next, the specificity of the Orlistat-based probe 2 ( Figure 1A ) toward FASN was further evaluated by performing competitive ABPP, in which prior to labeling with the corresponding probe, the proteome is incubated with an excess of different inhibitors, some of which compete for the same active site that the probe targets (Li et al., 2007) . For this purpose, the proteome was preincubated with known FASN inhibitors, such as Cerulenin and C75, which irreversibly inactivate the b-ketoacyl-ACP synthase domain but not the thioesterase domain of FASN (Moche et al., 1999; Pappenberger et al., 2010) , as well as 5-(tetradecyloxy)-2-furoic acid (TOFA), an established inhibitor of ACC (Halvorson and McCune, 1984) , the enzyme that catalyzes the production of malonyl-CoA, which is subsequently used as a substrate by FASN. As expected, in the presence of excessive amounts of Orlistat inhibitor, the Orlistat-based probe is outcompeted and cannot label the thioesterase domain of FASN ( Figure 1B,  lane 3) ; however, neither C75 nor Cerulenin abolishes the labeling of the Orlistat-based probe toward FASN ( Figure 1B , lanes 4-5), which indicates that the labeling is both target-and domain-specific. This shows that the probe can also be used to distinguish between different domains of FASN. The percentage activity remaining was determined by measuring the integrated optical density (IOD) of the FASN band relative to a DMSO-only (no inhibitor) control (Tsuboi et al., 2010) , normalized to a loading control (PTP-1D) ( Figure 1C) . Moreover, the heatdenatured proteome (D; first lane) did not show any labeling with Orlistat ABP, which further validates that the probe only targets the active enzyme. Collectively, these data show that the Orlistat-based probe has high specificity toward the (B) Fresh proteome isolated from Huh7 is incubated with 100 mM of inhibitors for 1 hr followed by labeling with 10 mM of Orlistat-based probe. D is the heatdenatured sample. (C) The percentage activity remaining was determined by measuring the IOD of the FASN band relative to a DMSO-only (no inhibitor) control normalized to a loading control (PTP-1D). The data represent the average of three independent gels. Error bars are SD. Also see Figure S1 .
thioesterase domain of FASN, and the attachment of the small alkyne handle does not change its preference in enzyme selectivity in Huh7 cells.
The Expression and Activity of FASN Increases during HCV Infection
Previous reports have demonstrated that de novo fatty acid synthesis is required for HCV replication (Kapadia and Chis- (F) Quantification of signal intensity for the band corresponding to FASN was followed by background correction. The results are shown as normalized FASN activity of infected relative to uninfected chimeric mice. The data represent the average of four independent gels. P value = 0.01, calculated by two-tailed Student's t test. Also see Figure S2 . ari, 2005; Su et al., 2002) , and HCV infection is associated with the accumulation of lipid in hepatocytes (i.e., steatosis). To further confirm the role of FASN activity in HCV replication, we used inhibitors of fatty acid synthesis to Huh7 cells that stably express a tricistronic HCV subgenomic replicon, with firefly luciferase reporter gene (Figure 2A ). At 48 hr posttreatment, the luciferase activity was examined as a measure of HCV replication. As shown in Figures 2B and 2C , in the presence of Orlisat, Cerulenin, and TOFA, HCV replication decreases by 50%, 70%, and 65%, respectively, compared with DMSO treatment. This is consistent with the integral role of fatty acid synthesis in HCV replication.
Moreover, in situ studies have demonstrated that FASN expression increases during HCV replication (Su et al., 2002; Yang et al., 2008) . To examine whether the activity of FASN is also elevated by the HCV replication, we applied comparative ABPP (Cravatt et al., 2008) , which compares the differential activity between healthy and virus-infected host proteomes.
Orlistat-based ABP ( Figure 1A ) was used to profile the activity of FASN in Huh7.5 cells harboring a full-length genotype 1b HCV genomic replicon (FGR) (Figure 2A ). The activity was determined by measuring the IOD of the band corresponding to FASN in the fluorescent gel, normalized to IOD of the band corresponding to a loading control (PTP-1D) in the respective western blot. In both in vitro and in situ labeling experiments, FASN activity increased by approximately 75% in the presence of HCV replicon, while FASN expression, determined by IOD of the FASN band in the western blot normalized to the loading control, increased by 45% ( Figures 2C and 2D) .
To further investigate the role of FASN in the HCV life cycle, we used an established mouse model for HCV infection in which primary human hepatocytes are transplanted into SCID mice carrying a plasminogen activator transgene (Alb-uPA). This model has been shown to support HCV infection without inducing an adaptive immune response (Mercer et al., 2001) . In this chimeric mouse model, HCV replication occurs at biologically relevant levels, and infectious viral particles are produced and released (Mercer et al., 2001; Walters et al., 2006) . We conducted ABPP experiments in chimeric SCID/Alb-uPA mice infected with HCV genotype 1a, which are more reflective of patient infections. Orlistat-based ABP was used on liver samples obtained from three chimeric mice that were infected with HCV genotype 1a and maintained the HCV infection for 10 weeks with serum titers between 2 3 10 5 and 4 3 10 7 copies/ml.
FASN activity was compared with the liver samples from three uninfected SCID mice harboring human primary hepatocytes (matched donors). As depicted in Figures 2E and 2F , HCV induces a 50% increase in the activity of FASN in the chimeric livers, with a p value of 0.01calculated by a two-tailed Student's t test. Moreover, this increase in the activity of FASN in the liver of infected chimeric mice is in agreement with its total abundance ( Figure S2 ). These findings provide additional evidence that FASN activity assists HCV replication and therefore its expression and activity is increased by the virus.
Modulation of the Activity and Expression of FASN by HCV-Encoded Proteins
FASN expression is primarily regulated at the transcriptional level by sterol response element-binding protein-1c (SREBP1c) (Horton et al., 2002) and some of the HCV structural and nonstructural proteins, including core (Jackel-Cram et al., 2007; Kim et al., 2007) , NS2 (Oem et al., 2008) , NS4B (Park et al., 2009) , and NS5A (García-Mediavilla et al., 2012; Xiang et al., 2010) , have been demonstrated to activate the SREBP1c transcriptional pathway, which can lead to increased transcription of lipogenic enzymes such as FASN. Moreover, studies have shown that the HCV proteins core and NS5A can activate the phosophoinositide-3 kinase (PI3K)-AKT pathway, which in turn leads to the activation of the SREBP-1 pathway (JackelCram et al., 2010; Street et al., 2005) . To study whether the activation of SREBP-1c pathway results in an increase in abundance of active FASN, we examined the alterations in the activity and expression of FASN in the presence of individual HCV proteins. For this purpose, we cloned and expressed the HCV proteins that have been shown to activate the SREBP-1c pathway in Huh7 cells, including E1/E2, core, NS2, NS4B, and NS5A. Forty-eight hours after transfection, cell lysate from each transfection was first analyzed by western blotting to ensure transfection success (data not shown), and subsequently the activity and expression of FASN was examined as mentioned before. The activity of FASN was significantly induced by NS4B, core, and NS5A, with 1.75-, 1.5-, and 1.4-fold increase compared to mock, respectively; while E1/E2 and NS2 do not seem to have a drastic effect on the activity and expression of FASN (p value > 0.05) ( Figures 3A and 3B) . The increase in the activity of FASN in the activity of FASN is in accordance with an increase in the abundance of total FASN ( Figure S3 ).
Increased FASN Activity Reflects in the Cellular Triglyceride Levels
The main product of FASN is the 16-carbon saturated fatty acid palmitate, which can be processed to be incorporated into triglycerides (Listenberger et al., 2003) . Therefore, to further study the changes in FASN activity induced by HCV and its proteins, we quantified the amount of cellular triglyceride (TG) levels as an indirect measurement of FASN activity. For this purpose, we analyzed cellular TG levels in Huh7 cells that stably express full-length HCV replicon (Huh7-FGR) or those transiently transfected with individual HCV proteins, or mock transfected Huh7 cells. As shown in Figure 4 , while NS4B, core, NS5A, and HCV replicon increased the total cellular TG content significantly, E1/E2 and NS2 did not cause a significant increase in cellular TG levels. Thus, we concluded that increased activity of FASN in the presence of HCV replicon, core, NS5A, and NS4B correlate with higher cellular TG levels.
The Localization of FASN Does Not Change during HCV Replication
Two of the HCV-encoded proteins, core and NS4B, are palmitoylated at the cysteine residues of their C-terminal ends, and this palmitoylation is essential for the replication of the virus (Majeau et al., 2009; Yu et al., 2006) . Palmitic acid produced by FASN can be subsequently used by palmitoyltransferase (PAT) for palmitoylation of certain cysteine residues (Dietrich and Ungermann, 2004) . It is possible that HCV requires FASN activity to palmitoylate core and NS4B. Furthermore, studies have shown that the distribution of FASN changes to colocalize with replication sites during infections with DENV, USUV, and WNV, which also belong to the Flaviviridae family, and require fatty acid synthesis for their replication (Heaton et al., 2010; Perera et al., 2012) . Therefore we decided to investigate whether the subcellular localization of FASN similarly changes during HCV replication to the vicinity of replication complexes in membranous webs or LD, where NS4B and core also localize (Barba et al., 1997; Elazar et al., 2004) . For this purpose, Huh7 cells expressing or not expressing the HCV subgenomic replicon (SGR) (genotype 1b, Figure 2A ) were immunostained with antibodies against FASN and HCV NS5A ( Figure 5A ), which associates with HCV replication complex (RC) (Gosert et al., 2003) , and dsRNA ( Figure 5B ), the HCV replication intermediate. The cells were subsequently analyzed by fluorescence microscopy and the image analyses revealed that the distribution and localization of FASN, which is mainly perinuclear, does not change in the presence or absence of the HCV replicon ( Figures 5A and 5B) .
To investigate the possibility of colocalization between total FASN and NS5A, or dsRNA, we calculated the degree of colocalization by measuring Mander's coefficient (R) and Pearson correlation coefficient (Rr). Mander's coefficient indicates an actual overlap of the signals and provides an estimation of the percentage of overlapped pixels. Its values vary from 0 to 1 (0 = nonoverlapping images and 1 = colocalized images); importantly, it strictly measures co-occurrence independent of signal proportionality (Dunn et al., 2011; Manders et al., 1993) . We also calculated the colocalization using the Pearson correlation coefficient, which measures the pixel-by-pixel covariance in the signal levels of two images, and describes the correlation of the intensity distribution between channels. The range for Pearson correlation coefficient is from À1 to 1 (À1 = total negative correlation, 0 = random correlation, and 1 = total positive correlation) (Adler and Parmryd, 2010; Zinchuk and Grossenbacher-Zinchuk, 2011) . The Mander's coefficient for overlapping signals between total FASN and NS5A, or dsRNA is 0.95 ± 0.03, and 0.93 ± 0.03, respectively. However, the Pearson correlation coefficient is only 0.53 ± 0.11 and 0.42 ± 0.09 for FASN and NS5A, or dsRNA, respectively. Therefore these data suggest that although there is some overlap between total FASN and NS5A, or dsRNA, there is a moderate or low correlation between their signal intensities, which is indicative of minimal molecular interaction between FASN and the HCV RC. Next we set to examine the distribution of active FASN during HCV replication, by combining ABPP imaging with immunofluorescence microscopy. For this purpose, we first validated the (B) Densitometry analysis of the bands corresponding to FASN on ABPP gels was performed by ImageJ, and the data were normalized to the loading control (PTP-1D) on corresponding western blots. The results are demonstrated as fold changes compared to mock and represent the mean from four gels of independent transfections. The error bars are SD. *p < 0.05, **p < 0.01, calculated by two-tailed Student's t test. Also see Figure S3 . specificity of the Orlistat-based probe by treating Huh7 cells and Huh7-SGR cells with the Orlisat-based probe, followed by conjugation to rhodamine azide through click chemistry and immunostaining against total FASN. As shown in Figure 6A , ABPP-labeled FASN evidently colocalizes with total antibodylabeled FASN and shows a similar perinuclear pattern in both mock Huh7 cells and Huh7-SGR. The calculated Mander's and Pearson coefficients for the colocalization of total FASN and ABPP-FASN, in the presence of the HCV subgenomic replicon, are 0.97 ± 0.03, and 0.93 ± 0.03, respectively, and in naive Huh7 cells are 0.99 ± 0.01 and 0.94 ± 0.02, which indicate that active FASN highly colocalizes with total FASN in the presence or absence of the HCV subgenomic replicon. Importantly, minimal fluorescence was observed in Huh7 cells and Huh7-SGR cells treated with the click mix only in the absence of the Orlistat probe ( Figure S4 ). There is also a considerable increase in the levels of active FASN detected in the presence of the HCV subgenomic replicon, which is consistent with previously shown data. Subsequently, we examined the possible relocalization of active FASN to the proximity of HCV RC by probing against active FASN and NS5A ( Figure 6B ; Figure S5A ) or dsRNA (Figure 6C ; Figure S5B ). As demonstrated, there is no apparent colocalization between active FASN and sites of active viral replication. Mander's and Pearson coefficients for ABPP-FASN and NS5A are 0.97 ± 0.01 and 0.61 ± 0.18, respectively, and for ABPP-FASN and dsRNA are 0.97 ± 0.015 and 0.63 ± 0.08. These results indicate that the overlap between signals from active FASN and NS5A or dsRNA do not represent a true colocalization, and can be explained by the drastic increase in the levels of FASN throughout the cytoplasm during HCV replication, which leads to a coincidental overlap between HCV RC that are also localize in the cytoplasm. Based on these results, we propose that the drastic increase in the activity and abundance of FASN during HCV replication leads to production of substantial amounts of fatty acids, and therefore HCV does not require the recruitment of FASN to the sites of active viral replication.
DISCUSSION
FASN abundance and de novo fatty acid synthesis are frequently deregulated in a wide range of human cancers, metabolic dis- eases, and viral infections (Menendez and Lupu, 2007; Menendez et al., 2009; Nguyen et al., 2010) , indicating the importance of targeting this enzyme for therapeutic purposes. While previous studies have demonstrated that FASN is indispensible for HCV replication and also that FASN abundance increases during HCV replication (Fukasawa et al., 2006; Oem et al., 2008; Su et al., 2002; Yang et al., 2008) , changes in FASN enzymatic activity and localization related to HCV propagation are not well understood. Herein we present the changes in enzymatic activity of FASN during HCV replication using activity-based protein profiling and activity-based imaging techniques.
Orlistat inhibits the activity of FASN by making an irreversible covalent bond to the active serine of the carboxy-terminal thioesterase (TE) domain of FASN . The TE domain is important because it determines the length of the fatty acyl chain by controlling its release from the enzyme complex . Therefore the TE domain plays a critical role in the terminal end of fatty acid biosynthesis, and using an ABPP probe to report on its catalytic activity would provide insight into the overall activity of FASN. Consequently we utilized Orlistat-based probes that were designed to specifically report on the functional state of FASN (Yang et al., 2010 (Yang et al., , 2012 to investigate the alterations in the activity of FASN during HCV replication.
Our results from ABPP studies both in cells expressing HCV proteins and in model systems for HCV propagation confirm the previous findings that HCV infection upregulates FASN expression at both transcriptional and protein levels and also demonstrate that the increase in FASN abundance during HCV replication leads to an increase in the overall FASN catalytic activity (Figure 2) . Importantly, the effect of HCV replication on the expression and activity of FASN was observed in both cell models harboring genotype 1b replicon as well as chimeric SCID/Alb-uPA mice containing human hepatocytes infected with HCV genotype 1a, which demonstrates that the modulation of FASN by HCV occurs in different model systems and appears to occur with different subtypes of HCV. Moreover, our results show that elevated FASN activity during HCV replication leads to an increase in cellular TG content, although the FASN activity and cellular TG levels are more highly correlated in the case of core and NS4B as compared with NS5A. This inconsistency can be explained by the fact that other than becoming TG and incorporated into LDs, the nascent fatty acids synthesized by increased expression and activity of FASN can have different fates, such as incorporation into membranes and as substrates for enzymes that posttranslationally lipidate (e.g., palmitoylate) protein targets. For example NS5A expression has been shown to activate phosophatydilinositol 3 kinase (PI3K) and PI4K (Street et al., 2005; Vaillancourt et al., 2012) , which in turn induce the synthesis of phosphoinositide 3 and 4 phosphate, respectively. These phosphoinositides are essential for the formation and integrity of endoplasmic reticulum (ER) as well as the HCVinduced membranous web (Street et al., 2005; Vaillancourt et al., 2012) .
Previous reports have demonstrated that expression of NS4B alone induces the formation of membranous webs (Gouttenoire et al., 2010; Liefhebber et al., 2009) , which are specific alterations in the ER membrane that harbor HCV RC. Additionally, it has been shown that NS4B expression activates the SREBP1 pathway that can lead to increased transcription of FASN (Ballinger and Peikin, 2002) . We observed a robust increase in both FASN activity and TG levels in the presence of NS4B ( Figures  3 and 4) , which may reflect the need for lipid components for HCV to induce membrane rearrangements. The expression of core protein has also been associated with increased cellular LD and activation of SREBP1 pathway. Consistent with this, our results demonstrated that core protein induces a significant increase in both FASN activity and TG levels. The involvement of NS4B and core in the induction of lipid biosynthesis and accumulation of lipid in hepatocytes may also contribute to the pathogenesis of liver steatosis in patients with chronic hepatitis C (Syed et al., 2010) . Interestingly, we observed higher levels of activity compared to the abundance of FASN in the presence of HCV. This could possibly be due to an influence of HCV on the posttranslational modifications of FASN that ultimately regulate its conformation and enzymatic activity. Future works will be directed toward understanding the role of HCV replication and its encoded proteins on posttranslational modifications of FASN and other lipogenic enzymes in the liver.
Recent reports have shown that FASN activity is required for other members of Flaviviridae, including DENV, WNV, and USUV (Heaton et al., 2010; Martín-Acebes et al., 2011; Perera et al., 2012) . Interestingly, during the replication of these viruses, the level of FASN abundance does not change; however, its distribution changes to colocalize with RC. In fact, Randall and coworkers demonstrated that the NS3 protein of DENV interacts with FASN and recruits it to the RC (Heaton et al., 2010) . Therefore, we investigated the possible colocalization of FASN with HCV replication sites by confocal microscopy. Our imaging results confirm the marked increase in FASN levels during HCV replication. However, in contrast to DENV, our imaging experiments show that FASN is not recruited to the HCV RC, because its localization remains similar in the absence or presence of the HCV replicon. More in-depth analysis of colocalization using image analysis methodologies helped us to address the question of HCV recruitment of FASN to replication sites.
The analysis of colocalization between FASN and NS5A or dsRNA, by calculating Mander's coefficient, revealed that there is some overlap between the signals, but because the Pearson coefficient, which is considered to be better than Mander's coefficient in quantifying colocalization (Adler and Parmryd, 2010) , is moderate for both sets of studies, it can be concluded that the overlap between FASN and NS5A or dsRNA is likely to be coincidental ( Figure 5 ). Interestingly, a parallel study by Huang and coworkers reported that HCV NS5B interacts with FASN, as deduced by immunoprecipitation, and this interaction appears to increase the RNA-dependent RNA polymerase (RdRp) activity (Huang et al., 2013 ). Herein we detected only a partial colocalization of FASN with HCV RC, which could still interact with NS5B, and enhance its RdRp activity. However, our study suggests that any interaction of NS5B (or other HCV proteins) with FASN is not sufficient to drastically alter FASN localization within the cell.
Next we analyzed whether HCV alters the distribution of active FASN, using ABPP imaging to visualize the localization of active FASN during HCV replication. Our results demonstrate that the ABPP-labeled FASN highly colocalizes with the antibodylabeled FASN, which confirms the specificity of ABPP imaging ( Figure 6 ). Colocalization analyses based on the Pearson coefficients (Adler and Parmryd, 2010) indicate that there is no significant colocalization between active FASN and either NS5A or dsRNA. Colocalization studies also confirm that active FASN is not recruited to the sites of HCV replication. However, the level of active FASN is considerably increased in Huh7-SGR cells and therefore there is some overlap between the signals from active FASN and NS5A or dsRNA, but these signals are not completely codependent. Consequently, we propose that the increases in FASN abundance and activity during HCV replication provides ample amounts of fatty acids and neutral lipids required for proper replication of the virus, and therefore there is no need for direct interaction and colocalization of FASN with the RC.
In summary, we demonstrated the application of ABPP to study the HCV-induced changes in the enzymatic activity of FASN. We showed that FASN expression is not only robustly induced during HCV replication, but this is commensurate with a significant increase in FASN catalytic activity. We also demonstrated that individual proteins such as core and NS4B are sufficient to induce FASN activity on their own and this increase in activity is correlated with increases in triglyceride neutral lipid products. Finally, fluorescence microscopy analyses show that colocalization of FASN with the RC is not required for HCV propagation, unlike other flaviviruses. These results also highlight the potential of activity profiles of enzymes such as FASN as prognostic markers of HCV infection.
EXPERIMENTAL PROCEDURES
Cell Culture Human hepatoma cells (Huh7) were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Burlington, ON, Canada) supplemented with 100 nM nonessential amino acids, 50 U/ml penicillin, 50 mg/ml streptomycin, and 10% fetal bovine serum (FBS, PAA Laboratories, Etobicoke, ON, Canada). The hepatoma cells stably expressing the HCV full-length replicon (genotype 1b, con1), a kind gift from Dr. Charles Rice (Rockefeller University, USA), were maintained in the same culture medium supplemented with 250 mg/ml G418 Geneticin (GIBCO-BRL, Burlington, ON). The pFK-I389neo/NS3-3 0 /5.1 subgenomic replicon was kindly provided by Dr. Ralf Bartenschlager (Institute of Hygiene, University of Heidelberg, Germany). were allowed to air-dry for 10 min, resuspended in 25 ml 1 3 standard reducing SDS-loading buffer, heated for 10 min at 95 C; and separated by 10% SDS-PAGE, then visualized by in-gel fluorescence scanning using the FMBIO Fluorescence Scanner (Hitachi). For in situ labeling, Huh7 cells were grown to 80%-90% confluence in sixwell plates under the conditions described previously. The medium was removed, and then cells were washed with PBS, and treated with 0.5 ml of DMEM-containing probe (20 mM), with or without Orlistat, C75, TOFA, or Cerulenin (200 mM). Probes were applied from DMSO stocks, while DMSO never exceeded 1% in the final solution. The same volume of DMSO was used as a negative control. After 2 hr of incubation at 37 C/5% CO 2 , the medium was aspirated, and cells were washed with PBS to remove the excessive probe, and lysed with 200 ml PBS containing 1% Triton. The lysate was then homogenized by sonication, and diluted to 1 mg/ml with PBS. Probe targets were detected by click chemistry with rhodamine azide, SDS-PAGE analysis, and in-gel fluorescence scanning.
Inhibitor Treatments
Western Immunobloting
Subsequent to in-gel fluorescence scanning, the proteome is transferred onto Hybond-P PVDF membrane (Amersham Biosciences). Thereafter, the membrane was blocked for 1 hr in 3% dried skim milk in Tris-buffered saline (TBS) with 0.05% Tween-20. Human FASN and protein tyrosine phosphatase 1D (PTP-1D, as the loading control), HCV core, E1/E2, NS2, NS4B, and NS5A, were targeted with a mouse monoclonal anti-FASN (2,000-fold dilution; Santa Cruz Biotechnology), a mouse monoclonal anti-PTD1B (10,000-fold dilution; BD Laboratories), a mouse monoclonal anti-HCV core (2,000-fold dilutions Abcam), a goat monoclonal anti-HCV E1 (1:2,000, Virostat), a mouse monoclonal anti-FLAG (2,000-fold dilutions, SIGMA), a mouse monoclonal anti-HCV NS4B (2,000-fold dilutions, Abcam), and a mouse monoclonal anti-NS5A (2,000-fold dilution; ViroStat), respectively. Bound primary antibody was detected with HRP-conjugated anti-mouse antibody, and the blots were developed using a chemoluminescent detection system (ECL prime, Amersham).
Measurement of Cellular Triglyceride Levels
At 48 hr posttransfection, lipids were extracted from 10 6 trypsinized cells. Triglyceride levels were analyzed directly by spectrophotometric analyses, using the triglyceride quantification kit (BioVision, Mountain View, CA), according to the manufacturer's instructions. Total protein levels were quantified with DC protein assay (BioRad). Triglyceride levels were expressed per milligram of protein.
Fluorescence Microscopy
Sixty percent to 70% confluent cells were fixed for 15 min with 4% paraformaldehyde and 4% sucrose in PBS. After two PBS washes, cells were permeabilized with 0.25% Triton_ X-100 (Sigma) in PBS for 5 min and blocked with 10% bovine serum albumin (BSA) in PBS for 30 min at 37 C. Immunofluorescence staining was performed by incubation with the following primary antibodies in 3% BSA/PBS: mouse monoclonal anti-NS5A (1:1,000; Chemicon International, Billerica, MA), rabbit monoclonal anti-FASN (1:50, Santa Cruz Biotechnology), and mouse monoclonal anti-dsRNA (1:3,000; Scicons, cat.no. 10010200). Consequently, the samples were washed three times with PBS for 5 min and incubated for 1 hr at 37 C in 3% BSA/PBS containing the respective secondary antibody: Rhodamine Red-X donkey anti-rabbit (1:1,000); or Cy2 donkey anti-mouse (1:1,000) (Jackson ImmunoResearch). Fluorescence images were collected using an Axiovert 200M inverted microscope (Carl Zeiss, Thornwood, NY) equipped with the Axiovision 3.1 software. The cells were then photographed with an AxioCam connected to the inverted microscope.
For ABPP imaging, the cells were incubated with an Orlistat probe (30 mM) for 4 hr in growth medium at 37 C and 5% CO 2 . Medium containing 1%
DMSO was used as a negative control. The cells were then washed twice with PBS, and fixed with 4% paraformaldehyde in PBS for 15 min at room temperature, washed with PBS (2 3 5 min with gentle agitation), and permeabilized with 0.1% Triton X-100 in PBS for 15 min at room temperature, and washed with PBS (2 3 5 min with gentle agitation). The cells were blocked with 3% BSA in PBS for 30 min at room temperature, and washed with PBS (2 3 5 min with gentle agitation). The cells were then treated with a freshly premixed click chemistry reaction solution of rhodamine azide (10 mM final concentration from a 10 mM stock solution in DMSO), TCEP (1 mM final concentration from a 50 mM freshly prepared stock solution in deionized water), TBTA (100 mM final concentration from a 10 mM stock solution in DMSO), and CuSO 4 (1 mM final concentration from a 100 mM freshly prepared stock solution in deionized water), in PBS for 1 hr at room temperature. The cells were washed with PBS (1 3 5 min with gentle agitation) and cold methanol (1 3 5 min with gentle agitation), followed by 1% Tween-20 and 0.5 mM of EDTA in PBS (3 3 2 min with gentle agitation), and with PBS (2 3 5 min with gentle agitation). For colocalization of FASN and HCV RC, indirect immunofluorescent cytochemical staining was carried out with either anti-NS5A or anti-dsRNA as described previously. Colocalization analyses were performed using colocalization analysis plug-in of ImageJ and the Mander's and Pearson's coefficient were calculated by Mander's calculator. The results are shown as the mean of five different image sets per sample, subsequent to background correction and exclusion of zero-zero pixels.
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